Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Arthur Cole, Ralf Schoenbrunner, Murali Prahalad

Premium

DNAnexus has appointed Arthur Cole as general manager of Europe. He will be based in the UK and will be responsible for the company's marketing, sales, and business development activities across the European market. He joins DNAnexus from Debon Strategic Partners, and was also previously executive vice president of Visible Genetics.


DiaDexus has appointed Ralf Schoenbrunner as senior vice president of research and early development. Previously, he was vice president of research and development andmolecular diagnostics at Life Technologies. He holds a PhD in physical biochemistry from the University of Bayreuth in Germany.


Epic Sciences has appointed Murali Prahalad as President and CEO. Prahalad joins Epic from Life Technologies where he was vice president of corporate strategy and helped shape investment priorities in research tools, clinical diagnostics, and applied markets.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.